Celestica Inc. (NYSE:CLS) will release earnings results for the third quarter, after the closing bell on Monday, Oct. 27. Analysts expect the Toronto, Canada-based company to report quarterly earnings ...
Revenue expanded from $5.6B in 2021 to $9.6B in 2024, with 2025 guidance raised to $11.55B. Q2 2025 revenue hit $2.89B, up 21% year-over-year, while adjusted EPS rose 54% to $1.39. Connectivity and ...
The move makes the Minneapolis-headquartered bank the service’s seventy-sixth settlement member, and the third to join in 2025. The addition of U.S. Bank aligns with a growing adoption of PvP ...
I ran into a reproducible problem when I stopped training mid-epoch and then resumed the next day from the saved last.pt. After resuming, classification loss (cls_loss) exploded (very large values), ...
Find out how CLS stock is currently doing: See the chart here. Total revenue was up 21% on a year-over-year basis, bolstered by “strong” adjusted operating margin. Celestica said it repurchased ...
Sierra View Medical Center is proud to celebrate the graduation of Michelle Vasquez, the newest Clinical Laboratory Scientist, CLS, program graduate. Vasquez is the ninth trainee to successfully ...
Celestica stock has had a strong run in recent weeks, but it might be time to take money off the table. Previous quarterly numbers were quite strong, which has led to upward EPS revisions for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback